Scilex Holding (SCLX) Depreciation and Depletion (2022 - 2026)

Scilex Holding (SCLX) posted quarterly Depreciation and Depletion of $800000.0 for Q1 2026, up 79900.0% year-over-year from N/an in Q1 2025, and up 215.08% on a QoQ basis from $253900.0 in Q4 2025.

Scilex Holding (SCLX) Depreciation and Depletion (2022 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Depreciation and Depletion for 5 consecutive years, with $800000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Depreciation and Depletion rose 79900.0% year-over-year to $800000.0; the TTM figure through Mar 2026 stood at $1.1 million (up 9517.27% YoY), while the FY2025 annual figure was $258900.0, up 1749.29% from the prior year.
  • Depreciation and Depletion came in at $800000.0 for Q1 2026 at Scilex Holding, up from $253900.0 in the prior quarter.
  • The five-year high for Depreciation and Depletion was $800000.0 in Q1 2026, with the low at $1000.0 in Q1 2025.
  • Average Depreciation and Depletion over 5 years is $68405.9, with a median of $10000.0 recorded in 2022.
  • Across the five-year window, Depreciation and Depletion slumped 75.0% in 2024 and jumped 79900.0% in 2026, its largest moves.
  • Year by year, Depreciation and Depletion stood at $10000.0 in 2022, then retreated by 20.0% to $8000.0 in 2023, then plunged by 75.0% to $2000.0 in 2024, then surged by 12595.0% to $253900.0 in 2025, then jumped by 215.08% to $800000.0 in 2026.
  • According to Business Quant data, Depreciation and Depletion over the past three periods registered $800000.0, $253900.0, and $2000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 188.00 Mn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 581.00 Mn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 93.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn 800,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 800,000.00
Mar 31, 2026 800,000.00
Dec 31, 2025 253,900.00
Dec 31, 2025 253,900.00
Sep 30, 2025 2,000.00
Sep 30, 2025 2,000.00
Jun 30, 2025 2,000.00
Jun 30, 2025 2,000.00
Mar 31, 2025 1,000.00
Mar 31, 2025 1,000.00
Dec 31, 2024 2,000.00
Dec 31, 2024 2,000.00
Sep 30, 2024 4,000.00
Sep 30, 2024 4,000.00
Jun 30, 2024 4,000.00
Jun 30, 2024 4,000.00
Mar 31, 2024 4,000.00
Mar 31, 2024 4,000.00
Dec 31, 2023 8,000.00
Dec 31, 2023 8,000.00